KWALITY PHARMACEUTICALS
Back to Income Statement
|
KWALITY PHARMACEUTICALS Last 5 Year Consolidated Net Profit History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Consolidated Net Profit | ₹40 Cr | ₹24 Cr | ₹19 Cr | ₹120 Cr | ₹15 Cr |
What is the latest Consolidated Net Profit of KWALITY PHARMACEUTICALS ?
| Year | Consolidated Net Profit |
|---|---|
| Mar2026 | ₹40 Cr |
| Mar2025 | ₹24 Cr |
| Mar2024 | ₹19 Cr |
| Mar2023 | ₹120 Cr |
| Mar2022 | ₹15 Cr |
How is Consolidated Net Profit of KWALITY PHARMACEUTICALS Trending?
| Years | Consolidated Net Profit | % Change | |
|---|---|---|---|
| Mar2026 | ₹40 Cr | 67.44 | |
| Mar2025 | ₹24 Cr | 22.83 | |
| Mar2024 | ₹19 Cr | -83.85 | |
| Mar2023 | ₹120 Cr | 692.23 | |
| Mar2022 | ₹15 Cr | - | |
Compare Consolidated Net Profit of peers of KWALITY PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| KWALITY PHARMACEUTICALS | ₹3,456.9 Cr | -8.4% | 28.4% | 228.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹456,114.0 Cr | NA | -3.9% | 17.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹239,321.0 Cr | 5% | 21.5% | 44.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹185,924.0 Cr | -2.1% | -0.2% | 34.3% | Stock Analytics | |
| CIPLA | ₹113,778.0 Cr | -2% | -2.5% | -8.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹99,025.9 Cr | 0.4% | 4.5% | -4.4% | Stock Analytics | |
KWALITY PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| KWALITY PHARMACEUTICALS | -8.4% |
28.4% |
228.5% |
| SENSEX | 0.7% |
0.8% |
-5.1% |
You may also like the below Video Courses